PROTEON THERAPEUTICS, INC. STOCK OPTION AGREEMENT (INCENTIVE STOCK OPTION OR NONSTATUTORY STOCK OPTION)Stock Option Agreement • September 16th, 2014 • Proteon Therapeutics Inc • Biological products, (no disgnostic substances)
Contract Type FiledSeptember 16th, 2014 Company IndustryPursuant to your Stock Option Grant Notice (“Grant Notice”) and this Stock Option Agreement, PROTEON THERAPEUTICS, INC. (the “Company”) has granted you an option under its 2006 EQUITY INCENTIVE PLAN (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Stock Option Agreement but defined in the Plan shall have the same definitions as in the Plan.
PROTEON THERAPEUTICS, INC. STOCK OPTION AGREEMENT (INCENTIVE STOCK OPTION OR NONSTATUTORY STOCK OPTION)Stock Option Agreement • June 25th, 2014 • Proteon Therapeutics Inc • Biological products, (no disgnostic substances)
Contract Type FiledJune 25th, 2014 Company IndustryPursuant to your Stock Option Grant Notice (“Grant Notice”) and this Stock Option Agreement, PROTEON THERAPEUTICS, INC. (the “Company”) has granted you an option under its 2006 EQUITY INCENTIVE PLAN (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Stock Option Agreement but defined in the Plan shall have the same definitions as in the Plan.
METABOLEX, INC. STOCK OPTION AGREEMENT (INCENTIVE STOCK OPTION OR NONSTATUTORY STOCK OPTION)Stock Option Agreement • August 12th, 2013 • CymaBay Therapeutics, Inc.
Contract Type FiledAugust 12th, 2013 CompanyPursuant to your Stock Option Grant Notice (“Grant Notice”) and this Stock Option Agreement, Metabolex, Inc. (the “Company”) has granted you an option under its 2003 Equity Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Stock Option Agreement but defined in the Plan shall have the same definitions as in the Plan.
METABOLEX, INC. STOCK OPTION AGREEMENT (INCENTIVE STOCK OPTION OR NONSTATUTORY STOCK OPTION)Stock Option Agreement • August 12th, 2013 • CymaBay Therapeutics, Inc.
Contract Type FiledAugust 12th, 2013 CompanyPursuant to your Stock Option Grant Notice (“Grant Notice”) and this Stock Option Agreement, Metabolex, Inc. (the “Company”) has granted you an option under its 2003 Equity Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Stock Option Agreement but defined in the Plan shall have the same definitions as in the Plan.
FIVE PRIME THERAPEUTICS, INC. STOCK OPTION AGREEMENT (INCENTIVE STOCK OPTION OR NONSTATUTORY STOCK OPTION)Stock Option Agreement • June 14th, 2013 • Five Prime Therapeutics Inc • Pharmaceutical preparations
Contract Type FiledJune 14th, 2013 Company IndustryPursuant to your Stock Option Grant Notice (“Grant Notice”) and this Stock Option Agreement, Five Prime Therapeutics, Inc. (the “Company”) has granted you an option under its 2002 Equity Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Stock Option Agreement but defined in the Plan shall have the same definitions as in the Plan.
RIGEL PHARMACEUTICALS, INC. AND STOCK OPTION AGREEMENT (INCENTIVE AND NONSTATUTORY STOCK OPTIONS)Stock Option Agreement • November 1st, 2011 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledNovember 1st, 2011 Company IndustryPursuant to your Stock Option Grant Notice (“Grant Notice”) and this Stock Option Agreement, RIGEL PHARMACEUTICALS, INC. (the “Company”) has granted you an option under its 2000 EQUITY INCENTIVE PLAN (the “2000 Plan”) or its 2011 EQUITY INCENTIVE PLAN (the “2011 Plan”), as identified on the Grant Notice (each to be referred to hereinafter, as applicable, as the “Plan”), to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Stock Option Agreement but defined in the Plan shall have the same definitions as in the Plan.
DEVAX, INC. STOCK OPTION AGREEMENT (INCENTIVE AND NONSTATUTORY STOCK OPTIONS)Stock Option Agreement • May 4th, 2007 • Devax Inc
Contract Type FiledMay 4th, 2007 CompanyPursuant to your Stock Option Grant Notice (“Grant Notice”) and this Stock Option Agreement, Devax, Inc. (the “Company”) has granted you an option under its 1999 Equity Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Stock Option Agreement but defined in the Plan shall have the same definitions as in the Plan.
EXELIXIS, INC. Stock Option Agreement (Incentive and Nonstatutory Stock Options)Stock Option Agreement • November 8th, 2004 • Exelixis Inc • Services-commercial physical & biological research
Contract Type FiledNovember 8th, 2004 Company IndustryPursuant to your stock option grant as evidenced by the Certificate of Stock Option Grant on the Smith Barney Stock Plan Services website (“the Grant Certificate”) and this Stock Option Agreement, Exelixis, Inc. (the “Company”) has granted you an option under its 2000 Equity Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Certificate at the exercise price indicated in your Grant Certificate. Defined terms not explicitly defined in this Stock Option Agreement but defined in the Plan shall have the same definitions as in the Plan.